---
title: Building A Market Access Blueprint For Lung Cancer Diagnostics In Asia-Pacific
description: Discover how Clearstate developed a market access strategy for lung cancer diagnostics in APAC to address disparities and drive future growth.
image: https://clearstate.com/hubfs/robina-weermeijer-Pw9aFhc92P8-unsplash-1536x864.jpg
---

[![logo](https://clearstate.com/hubfs/Asset%203@3x-8.png)](https://clearstate.com/)

[![logo](https://clearstate.com/hubfs/Asset%203@3x-8.png)](https://clearstate.com/)

[![logo](https://clearstate.com/hubfs/Asset%203@3x-8.png)](https://clearstate.com/)

![x](https://clearstate.com/hubfs/x.svg)

- Data Insights
  
  #### Data Insights
  
  Access market size, share, growth data and profiling solutions to guide strategy in diagnostics, surgical devices and life sciences markets.

  ##### [Size & Share Tracker Explore market sizing and share insights across key healthcare verticals. Stay updated with granular data and trends.](https://clearstate.com/business-intelligence/size-share-tracker)
  
  ##### [LabPro Access detailed lab profiles and datasets to guide partnership and sales targeting.](https://clearstate.com/business-intelligence/labpro)
  
  ##### [AsiaQCI Specialized solution tracking Asian medical device companies, products, and innovation movements.](https://clearstate.com/business-intelligence/asia-qci)
- [Bespoke Research](https://clearstate.com/bespoke-research)
- Thought Leadership
  
  #### Resources
  
  Explore expert insights, research publications, and thought leadership content.

  ##### [Whitepapers Detailed reports and insights from Clearstate’s healthcare experts.](https://clearstate.com/whitepapers)
  
  ##### [Case Studies Examples demonstrating the impact and results for clients.](https://clearstate.com/case-studies)
  
  ##### [Events Stay informed about upcoming conferences, webinars, and industry gatherings.](https://clearstate.com/events)
- Company
  
  #### About Clearstate
  
  Learn about Clearstate’s mission, leadership, and career opportunities.

  ##### [About Us Our mission, vision, and milestones shaping healthcare market intelligence.](https://clearstate.com/about-us)
  
  ##### [Careers Explore opportunities to join a dynamic, insights-driven organization](https://clearstate.com/careers)
  
  ##### [Contact Us Have questions? We’re here to help you make informed decisions.](https://clearstate.com/contact-us)

 ...

### Menu

- Data Insights
- [Bespoke Research](https://clearstate.com/bespoke-research)
- Thought Leadership
- Company

### Data Insights

- #### [Size & Share Tracker Explore market sizing and share insights across key healthcare verticals. Stay updated with granular data and trends.](https://clearstate.com/business-intelligence/size-share-tracker)
- #### [LabPro Access detailed lab profiles and datasets to guide partnership and sales targeting.](https://clearstate.com/business-intelligence/labpro)
- #### [AsiaQCI Specialized solution tracking Asian medical device companies, products, and innovation movements.](https://clearstate.com/business-intelligence/asia-qci)

### Thought Leadership

- #### [Whitepapers Detailed reports and insights from Clearstate’s healthcare experts.](https://clearstate.com/whitepapers)
- #### [Case Studies Examples demonstrating the impact and results for clients.](https://clearstate.com/case-studies)
- #### [Events Stay informed about upcoming conferences, webinars, and industry gatherings.](https://clearstate.com/events)

### Company

- #### [About Us Our mission, vision, and milestones shaping healthcare market intelligence.](https://clearstate.com/about-us)
- #### [Careers Explore opportunities to join a dynamic, insights-driven organization](https://clearstate.com/careers)
- #### [Contact Us Have questions? We’re here to help you make informed decisions.](https://clearstate.com/contact-us)

![menu (10) 1](https://clearstate.com/hubfs/menu%20(10)%201.svg)

![\<span id="hs\_cos\_wrapper\_name" class="hs\_cos\_wrapper hs\_cos\_wrapper\_meta\_field hs\_cos\_wrapper\_type\_text" style="" data-hs-cos-general-type="meta\_field" data-hs-cos-type="text" \>Building A Market Access Blueprint For Lung Cancer Diagnostics In Asia-Pacific\</span\>](https://clearstate.com/hubfs/robina-weermeijer-Pw9aFhc92P8-unsplash-1536x864.jpg)

# Building A Market Access Blueprint For Lung Cancer Diagnostics In Asia-Pacific

 Mon, 01st Dec 2025

[APAC](https://clearstate.com/case-studies/tag/apac) [IVD](https://clearstate.com/case-studies/tag/ivd)

## Discover the insights from APAC’s lung cancer landscape that helped map out the future of market access in eight countries

 

Lung cancer is the leading cause of cancer mortality in the Asia-Pacific (APAC) region, with annual deaths expected to increase to over 1.8m by 2040. In-vitro diagnostics (IVD) technologies such as immunoassays, tissue diagnostics, next-generation sequencing and PCR liquid biopsy are used to test for lung cancer biomarkers.

An IVD multinational company is developing its corporate strategy to help tackle the disease in APAC based on the current and future direction of the market access, reimbursement landscape, and the patient journey in APAC markets.

#### **Building a market access blueprint for lung cancer in APAC**

To build a market access blueprint for the client, Clearstate assessed the use of IVD testing for lung cancer and the state of market access in eight countries. 

Through primary and secondary research, we mapped the lung cancer testing landscape from the disease perspective covering the overall patient journey in each country covering the patient volume and diagnosis rate, treatment paradigm, IVD adoption status; and the market access perspective, covering national health plans, IVD approvals and reimbursement status, pricing, policy trends. Clearstate also built a sizing forecast model to estimate the sales value across all target APAC countries. 

Through the study, gaps and disparities around IVD testing across the care pathway and the region were uncovered. Despite a similar population size at around 1.43bn, China ran almost 800 times more lung cancer immunoassay tests in 2022 than India, largely as a result of clinical guidelines that recommend immunoassay tests for lung cancer diagnosis and tracking.

Based on our findings, the eight countries were grouped based on their level of development in the lung cancer care pathway: (1) developed markets in APAC such as Japan and South Korea which have a well-integrated care pathway to provide more targeted treatment for patients; (2) countries such as China with a sharp rural-urban divide in lung cancer care access and (3) developing markets such as India, Indonesia and Vietnam where access to testing and treatment is constrained by affordability.

# Clearstate consulting

 Assess and plan around opportunities to enter new markets.Find out how Clearstate can support your go-to-market strategy.

[FIND OUT MORE](https://clearstate.com/)

#### Share This Story, Choose Your Platform!

[![Facebook](https://5655711.fs1.hubspotusercontent-na1.net/hubfs/5655711/043-facebook-1.svg) Facebook](https://www.facebook.com/sharer.php?u=https://clearstate.com/case-studies/building-a-market-access-blueprint-for-lung-cancer-diagnostics-in-asia-pacific-1&t=Building%20A%20Market%20Access%20Blueprint%20For%20Lung%20Cancer%20Diagnostics%20In%20Asia-Pacific) [![Twitter](https://5655711.fs1.hubspotusercontent-na1.net/hubfs/5655711/013-twitter-1.svg) Twitter](https://twitter.com/share?url=https://clearstate.com/case-studies/building-a-market-access-blueprint-for-lung-cancer-diagnostics-in-asia-pacific-1&text=Building%20A%20Market%20Access%20Blueprint%20For%20Lung%20Cancer%20Diagnostics%20In%20Asia-Pacific) [![WhatsApp](https://5655711.fs1.hubspotusercontent-na1.net/hubfs/5655711/Vector-3.svg) WhatsApp](https://api.whatsapp.com/send?text=https://clearstate.com/case-studies/building-a-market-access-blueprint-for-lung-cancer-diagnostics-in-asia-pacific-1) [![Reddit](https://5655711.fs1.hubspotusercontent-na1.net/hubfs/5655711/024-reddit.svg) Reddit](http://reddit.com/submit?url=https://clearstate.com/case-studies/building-a-market-access-blueprint-for-lung-cancer-diagnostics-in-asia-pacific-1&title=Building%20A%20Market%20Access%20Blueprint%20For%20Lung%20Cancer%20Diagnostics%20In%20Asia-Pacific) [![Email](https://5655711.fs1.hubspotusercontent-na1.net/hubfs/5655711/mail%201.svg) Email](mailto:?subject=Building%20A%20Market%20Access%20Blueprint%20For%20Lung%20Cancer%20Diagnostics%20In%20Asia-Pacific&body=Link:https://clearstate.com/case-studies/building-a-market-access-blueprint-for-lung-cancer-diagnostics-in-asia-pacific-1) [![LinkedIn](https://5655711.fs1.hubspotusercontent-na1.net/hubfs/5655711/Social%20Icons.svg) LinkedIn](https://www.linkedin.com/shareArticle?mini=true&url=https://clearstate.com/case-studies/building-a-market-access-blueprint-for-lung-cancer-diagnostics-in-asia-pacific-1&title=Building%20A%20Market%20Access%20Blueprint%20For%20Lung%20Cancer%20Diagnostics%20In%20Asia-Pacific)

## Related Case Studies Blogs

## Contact Us

Every MedTech journey is different - let us know yours, and we’ll deliver the insights that give you an edge

[![clearstate\_cover 2](https://clearstate.com/hubfs/clearstate_cover%202.png)](https://clearstate.com/)

##### Data Insights

[Size and Share Tracker](https://clearstate.com/business-intelligence/size-share-tracker)

[LabPro](https://clearstate.com/business-intelligence/labpro)

[AsiaQCi](https://clearstate.com/business-intelligence/asia-qci)

##### [Bespoke Research](https://events.clearstate.com/bespoke-research)

##### Thought Leadership

[Whitepapers](https://clearstate.com/whitepapers)

[Case Studies](https://clearstate.com/case-studies)

[Events](https://clearstate.com/events)

##### Company

[About Us](https://clearstate.com/about-us)

[Careers](https://clearstate.com/careers)

<https://clearstate.com/contact-us>

##### Connect with Us

[![linkedin (4) 1](https://clearstate.com/hubfs/linkedin%20(4)%201.svg)](https://www.linkedin.com/company/clearstate/)

---

 © clearstate 2026. All Rights Reserved.

[Privacy Policy](https://events.clearstate.com/privacy-policy)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Clearstate",
    "url" : "https://clearstate.com/case-studies/author/clearstate"
  },
  "dateModified" : "2025-12-17T17:13:48.690Z",
  "datePublished" : "2025-12-01T15:16:05.000Z",
  "headline" : "Building A Market Access Blueprint For Lung Cancer Diagnostics In Asia-Pacific",
  "image" : [ "https://clearstate.com/hubfs/robina-weermeijer-Pw9aFhc92P8-unsplash-1536x864.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://clearstate.com/case-studies/building-a-market-access-blueprint-for-lung-cancer-diagnostics-in-asia-pacific-1",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://clearstate.com/hubfs/clearstate_cover%202.png"
    }
  }
}
```